Skip to main content
. 2017 May 12;8(8):1355–1361. doi: 10.7150/jca.18014

Table 2.

Preoperative plasma mesothelin of colorectal cancer cases in subgroups.

Variables Cases, N Mesothelin (ng/ml) Pa
Age (years)
≤ 60 73 (49.7%) 35.72 ± 16.01 0.800
> 60 74 (50.3%) 35.95 ± 16.12
Sex
Male 83 (56.5%) 35.07 ± 14.88 0.618
Female 64 (43.5%) 36.82 ± 17.44
Smoking status
Never 104 (70.8%) 35.50 ± 16.00 0.723
Ever 43 (29.2%) 36.64 ± 16.19
Drinking status
Never 106 (72.1%) 35.97 ± 16.32 0.981
Ever 41 (27.9%) 35.48 ± 15.37
FH
No 110 (74.8%) 35.13 ± 15.54 0.427
Yes 37 (25.2%) 37.93 ± 17.38
Tumor site
Colon 73 (49.7%) 34.87 ± 15.75 0.455
Rectal 74 (50.3%) 36.79 ± 16.32
Tumor size
≤ 4.0 cm 71 (60.2%) 35.85 ± 17.14 0.857
> 4.0 cm 47 (39.8%) 34.76 ± 14.60
Tumor grade
Low + Intermediate 120 (81.6%) 34.90 ± 16.39 0.064
High 27 (18.4%) 40.01 ± 13.68
Duke's stage
A + B 74 (50.3%) 30.47 ± 13.38 < 0.001
C + D 73 (49.7%) 41.27 ± 16.70

aTwo-sided Wilcoxon test for statistical differences between different groups

FH, family history of cancers